| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| 12:34 | Patria Private Equity Trust - Curated exposure to rebounding European PE | 140 | Patria Private Equity Trust (PPET) delivered a 10.6% NAV total return (TR) in sterling terms in FY25 (ended September 2025), despite the tariff-induced macroeconomic uncertainty that resulted in muted... ► Artikel lesen | ||
| 09:34 | Greggs - Market share gains in difficult market | 213 | Greggs' FY25 results reflect the negative operating leverage from lower volumes, which have continued into FY26, as well as the incremental costs from infrastructure investment. These combined to reduce... ► Artikel lesen | ||
| Mi | OPAP - Going out on a high | 301 | OPAP delivered a strong final set of results before the expected completion of the combination with Allwyn that were ahead of management's guidance from the start of the year from a revenue perspective... ► Artikel lesen | ||
| Mi | Netcall - H126 quality despite recent price weakness | 165 | Netcall represents a quality investment. The primary H126 growth driver was expansion at existing customers, illustrating the continued upside from the user base. Added to this are growing recurring... ► Artikel lesen | ||
| Mi | Freelancer Limited - Operational improvements boost profits | 216 | Modest revenue growth combined with careful cost control resulted in record adjusted operating profit and net income for FY25. Increasing demand in the Loadshift business helped drive Freelancer divisional... ► Artikel lesen | ||
| Mi | Pan African Resources - Up 17 times in 15 years | 207 | Pan African's EPS for H126 were 2.7% ahead of our prior forecasts on a headline basis and 27.0% ahead on a normalised basis (see Exhibit 2). Management reiterated guidance for FY26 at 275-292koz, albeit... ► Artikel lesen | ||
| Di | SynAct Pharma - Multiple shots on goal in 2026 for resomelagon | 188 | SynAct Pharma's FY25 results reflect a year of solid execution, highlighted by the continued advancement of lead asset resomelagon in the Phase IIb ADVANCE trial in rheumatoid arthritis (RA). With enrolment... ► Artikel lesen | ||
| Di | Borussia Dortmund - Concentrating on the Bundesliga | 319 | Borussia Dortmund's first team was unsuccessful in reaching the Round of 16 of the Champions League, which is a key assumption when management provides its guidance at the start of the financial year.... ► Artikel lesen | ||
| Di | OSE Immunotherapeutics - Reaffirmed dedication to core assets | 248 | OSE Immunotherapeutics has reaffirmed its strategy of streamlining its clinical pipeline following some developments to its partnered assets. For ABBV-230 (OSE-230), partnered with AbbVie, OSE had previously... ► Artikel lesen | ||
| Di | PCI-PAL - Good progress on all fronts | 221 | PCI Pal made good progress towards its strategic objectives in H126. As well as growing end-H126 annual recurring revenue (ARR) by 21% y-o-y (25% in constant currency, cc) and contracted ARR (CARR)... ► Artikel lesen | ||
| Di | The Diverse Income Trust - Roll over into open-ended fund or cash exit | 196 | Since its launch in April 2011, the Diverse Income Trust (DIVI) has outperformed the UK market and all but one of its 17 AIC UK Equity Income sector peers. Its dividend record has also been stronger... ► Artikel lesen | ||
| Mo | International Airlines Group - Record profit with robust returns | 307 | International Airline Group (IAG) delivered a record FY25 operating profit that reflects both favourable market dynamics and its portfolio strength, with an operating margin (15.1%) at the top end and... ► Artikel lesen | ||
| Mo | Games Workshop Group - From tabletop to top line | 264 | Games Workshop Group (GAW) is a vertically integrated designer, manufacturer and distributor of fantasy miniatures and tabletop games, which have high customer loyalty. A combination of improved product... ► Artikel lesen | ||
| Mo | Devolver Digital - Four reasons to invest: right time, right place, right team, right price | 159 | We believe that Devolver Digital has turned a corner and that the group's current valuation is at a significant discount to fair value. We expect indie games to perform strongly as the market returns... ► Artikel lesen | ||
| Fr | NFON - FY25 preliminary results show stability | 350 | The theme of NFON's FY25 preliminary results announced on 26 February is stability. While market conditions remain challenging, seat numbers seem to be stabilising and management continues to invest... ► Artikel lesen | ||
| Fr | HELLENiQ ENERGY - EBITDA rebased at more than €1bn | 272 | HELLENiQ ENERGY reported FY25 adjusted EBITDA of €1,132m, up 10% y-o-y, and adjusted net income of €503m, up 25% y-o-y, marking the fourth consecutive year of more than €1bn EBITDA. Management believes... ► Artikel lesen | ||
| Fr | Webinar: Blackrock Latin American Investment Trust (Video) | 187 | This webinar was hosted by Milosz Papst, head of investment trust content at Edison, and featured Sam Vecht, lead co-manager of BlackRock Latin American Investment Trust (ticker: BRLA). This was a lively... ► Artikel lesen | ||
| 26.02. | Earnz - Contract wins drive buy-and-build momentum | 228 | EARNZ's announcement of two significant new contracts, with a combined initial value of c £4.7m, reinforces management's confidence in building a scalable energy services platform aligned to the UK's... ► Artikel lesen | ||
| 26.02. | PWO Group - Preliminary FY25 results better than expected | 335 | PWO's preliminary FY25 results were better than expected, in terms of both revenues and EBIT before currency effects. The lifetime volume of new business was very strong at €760m, exceeding guidance... ► Artikel lesen | ||
| 26.02. | Georgia Capital - FY25 NAV total return of over 60% | 263 | Georgia Capital (GCAP) delivered a very strong NAV total return (TR) of 61.2% in FY25 in Georgian lari terms (56.4% in sterling terms), aided primarily by the almost doubling share price of Lion Finance... ► Artikel lesen | ||
| 26.02. | Altron - Platform businesses drive upgrades | 245 | In its pre-close operational update, Altron provided more detail on year-to-date performance (11 months to 31 January 2026), confirming that EBITDA from continuing operations grew in the mid-teens and... ► Artikel lesen | ||
| 26.02. | AVI Global Trust - Double-digit NAV returns from undervalued assets | 230 | AVI Global Trust (AGT) has been managed by Joe Bauernfreund at Asset Value Investors (AVI) since September 2015. During his tenure, the trust's NAV has compounded at an annual rate of 11.6%. He invests... ► Artikel lesen | ||
| 25.02. | British American Tobacco - Strategy driving momentum | 583 | British American Tobacco's (BAT's) FY25 results demonstrate meaningful progress on its transformation. In addition to releasing results at the top end of expectations, which had been upgraded twice... ► Artikel lesen | ||
| 25.02. | The London Tunnels - Private market availability | 305 | The London Tunnels is available to investors via regulated brokers on JP Jenkins (JPJ). JPJ operates a private market liquidity and access platform that enables investors to invest in private (unlisted)... ► Artikel lesen | ||
| 24.02. | BB Biotech - Continuing to outperform the benchmark | 424 | BB Biotech (BION) delivered strong 2025 results, with NAV increasing 26.5% (in Swiss franc terms), comfortably outperforming BION's benchmark, the Nasdaq Biotech Index (NBI), which gained 16.6% over... ► Artikel lesen |